Sotera Health Affirms FY2026 Adj EPS Guidance of $0.95-$1.01 vs $0.98 Est; Lowers FY2026 Sales Guidance from $1.236B-$1.254B to $1.233B-$1.250B vs $1.247B Est
Benzinga Newsdesk 6 hours ago
NewsGuidance
Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.95-$1.01 to $0.95-$1.01 vs $0.98 analyst estimate. Lowers FY2026 sales outlook from $1.236 billion-$1.254 billion to $1.233 billion-$1.250 billion vs
Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.95-$1.01 to $0.95-$1.01 vs $0.98 analyst estimate. Lowers FY2026 sales outlook from $1.236 billion-$1.254 billion to $1.233 billion-$1.250 billion vs $1.247 billion estimate.